Endocrinology - Diabetes Flashcards

1
Q

Normal fasting glucose levels

A

Up to 6mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Impaired fasting glucose levels

A

6-7mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Diabetic fasting glucose levels

A

> 7mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology T1DM

A

Autoimmune disease w/ antibodies targeted against B cells –> cell death Inadequate Insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PS T1DM (1st ep)

A

2-6w Hx of
Polyuria
Polydipsia
W loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathophysiology T2DM

A

Blood levels insulin initially normal
Insulin resistance
Beta cells then decompensate and stop XS insulin production –> hyperglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PS T2DM

A

Over m/y
Lack of E
Visual blurring
Pruritis vulvae/balanitis b/c candida infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PS older pt of T2DM

A
Retinopathy 
Polyneuropathy 
ED 
Aa disease 
Staph skin infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hereditary links T1DM

A

HLA-DR3/DR4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Concordance in twins - T1DM

A

30-50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Concordance in twins - T2DM

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2’ causes of DM

A
CF
Chronic pancreatitis 
Pancreatectomy 
Hereditary haemochromatosis 
Carcinoma pancreas 
Cushing's 
Acromegaly 
Thyrotoxicosis 
Phaeochromocytoma 
Glucagonoma 
Drug induced 
Freidreich's ataxia 
Dystrophia myotonica
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HbA1c levels diabetic

A

> 48mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pre-diabetic levels HbA1c

A

42-7mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Who would using HbA1c be inappropriate in?

A
<18 y/o 
T1DM
Pregnancy 
Acutely unwell 
Those on meds that raise blood sugars 
Any haemolytic disorder 
ESRD
HIV
certain drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Patients taking which 3 drugs would it be inappropriate to do a HbA1c on

A

Dapsone
Erythropoetin
Ribavirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

75g glucose load test - normal values

A

fasting < 7

2 h < 7.8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

75g glucose load test - impaired fasting glucose

A

Fasting 6.1-7

2h <7.8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

75g glucose load test - imapired glucose tolerance

A

Fasting <7

2h 7.8-11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

75g glucose load test - DM

A

fasting <7

2h >11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

+ves of HbA1c over glucose tests (3)

A

Non-fasting
Quicker for patient than GGT
Avoids glucose load

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Genetic linkage MODY

A

Autosomal dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When should you suspect T1DM in a patient > 40?

A

If comorbid autoimmune disease

And BMI <25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Non-medication Mx T2DM (9)

A
Individualised care plan 
Group education programme 
Screen - complications 
Monitor CV risk 
Diet advice 
Weight loss (5-10%) 
Increase PAL 
Stop smoking 
Alcohol advice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Alcohol advice for pt w/ DM

A

Limit intake

Carb containing snack before and after consumption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How to monitor CV risk for pt w/ T2DM

A

BP control

Qrisk score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Relevance of Qrisk score + T2DM

A

If 10y risk >10% - offer 20mg atorvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Screening for complications yearly T2DM (3)

A

Fundoscopy
Nephropathy screen
Foot check

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Target HbA1c diabetics

A

6.5% (48)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

1st line Dx regime T2DM

A

Metformin - 500mg od –> every meal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

1st line Dx regime T2DM if metformin isn’t tolerated/CI

A
Gliptin 
Or
Thiazolidinedone 
Or 
Sulphonylurea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

2nd line Dx regime T2DM

A

Metformin + 2nd Dx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

3rd line Dx regime T2DM

A
Triple therapy 
= Metformin
\+ 
Sulphonylurea
\+
Gliptin/pioglitazone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Alternative to triple therapy T2DM if metfomin C/I

A

Insulin regimen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Mode of action Metformin

A

Decr hepatic glucose prod

Increase peripheral insulin sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

C/I metformin (4)

A

eGFR 30 or <
Alcoholic
If pt risk lactic acidosis (DKA)
If Pt at risk tissue hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What must be monitored when on metformin annually

A

Renal fct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

SE metformin (3)

A

GI Sx
Lactic acidosis
Vit B12 defic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

E.g. S acting Sulphonylureas

A

Tolbutamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

E.g. Med acting Sulphonylureas

A

Glicazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

E.g. long acting Sulphonylureas

A

Glibenclamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Mode of action Sulphonylureas

A

Increase insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Who should Sulphonylureas be prescribed with caution? (2)

A

Elderly - risk hypoglycaemic events

Obese

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

SE Sulphonylureas (2)

A

Norm well tolerated
GI
LIver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

E.g. of Thiazolidinediones

A

Pioglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

mode of action Thiazolidinediones

A

PPARy activators - increase peripheral insulin senstivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

SE Thiazolidinediones (4)

A

Fl retention
W gain
Liver dysfunction
Bladder cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What must be monitored with Thiazolidinediones

A

LFTs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Who are Thiazolidinediones C/I in ?

A

CCF

Because of fl retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

E.g. of gliptin

A

Sitagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Mode of action gliptin

A

DPP-4 inhibitors

Increase post prandial release

52
Q

Who to avoid gliptins in?

A

Cardiac
Hepatic
Renal dysfunction

53
Q

SE gliptins (2)

A

GI disturbance

Rarely acute pancreatitis

54
Q

E.g. of GLP-1 mimetics

A

Enaxatide

55
Q

Who qualifies for trial of GLP-1 mimetics ?

A

If BMI >35

Or <35 + Other co-morbidities/insulin therapy would have negative occu impacts

56
Q

SE GLP-1 mimetics (2)

A

GI

Rarely acute pancreatitis

57
Q

DAFNE

A

Dose adjusted for normal eating

58
Q

Aim of short acting insulins

A

Mimic bodys insulin secretion in response to food

59
Q

E.g. of rapid acting short acting insulins (2)

A

humalog

Novoramid

60
Q

When are rapid acting short acting insulins administered/

A

with or just after food

61
Q

Onset of action time rapid acting short acting insulins

A

15 mins

62
Q

Duration action rapid acting short acting insulins

A

2-5hrs

63
Q

E.g.s of soluble short acting insulins (2)

A

Actarapid

Humulin S

64
Q

When are soluble short acting insulins administered?

A

30 mins before food

65
Q

Duration of action soluble short acting insulin?

A

Up to 8 hours

66
Q

Aim of intermediate acting insulins

A

Mimic basal insulin secretion

67
Q

e.g.s of intermediate acting insulins (2)

A

Humulin I

Insulatard

68
Q

Onset time intermediate acting insulins

A

1-2hours

69
Q

Duration intermediate acting insulins

A

16-35hrs

70
Q

Aim of long acting insulins

A

Mimic basal insulin secretion

71
Q

E.gs of long acting insulins (4)

A

Lantus
Levemir
Tresiba
Detemir

72
Q

Which insulin regime is recommended T1DM? /

A

Basal bolus
b.d long acting
Rapid acting wih each meal

73
Q

Insulin regime T2DM

A

continue metformin Tx
Intermediate acting insulin o.d./b.d.
biphasic preps in HbA1c partic high

74
Q

Complications of insulin therapy

A
Weight gain 
Insulin resistance 
Pain, redness, swelling at injection site 
Lipohypertrophy at injection site
injection site abscess
75
Q

Define ketosis

A

Elevated plasma ketone levels in absence of acidosis

76
Q

Which type of diabetic gets DKA

A

T1DM

77
Q

3 circumstances under which DKA occurs (3)

A

Prev undiagnosed DM
Interruption of insulin therapy
Stress of intercurrent

78
Q

biochemical features DKA (5)

A
Hyperglycaemia >10 
Kertones +ve 
HCO3- - low 
Plasma Na - usually low 
Plasma K+ - high or norm/high
79
Q

PS DKA (8)

A
Prostration 
Kussmaul resp
N+V
Abdo pain 
Confusion/stupor 
Coma
Skin dry
Marked polyuria
80
Q

Ix DKA (7)

A
U+E
Creatinine 
Blood glucose 
VBG
ECG
CXR
Pregnancy
81
Q

How is the severity of DKA determined

A

pH

82
Q

mild DKA

A

pH >7.3

83
Q

mod DKA

A

pH 7.1-7.3

84
Q

severe DKA

A

pH <7.1

85
Q

Immediate Tx DKA

A

A-E
1L 0.9%NaCl over 1hr
IV insulin

86
Q

How to do the bags of NaCl IV for DKA Tx

A

bag 1 - 1L over 1hr
bag 2 - 1L over 2hr
bag 3 - 1L over 2hr
bag 4- 1L over 4hr

87
Q

How to change management for DKA patient after recovery?

A

–> SC insulin when pt can eat/drink + pH>7.3
Stop IV infusion 1hr after SC starts
Rx to DM team

88
Q

Which type of diabetes gets HHS?

A

T2DM

elderly, usually previously undiagnosed

89
Q

Precipitating factors HHS (3)

A

Consuming glucose rich foods
Meds - thiazide diuretics, steroids, b blockers
Illness - infection/MI

90
Q

CF HHS (2)

A

Dehydration

Stupor/coma

91
Q

Diagnosing HHS (6)

A
Osm >320 
Severe hyperglycaemia (often >40) 
Ketones - -ve 
HCO3 - -ve 
Plasma Na+ - v high 
Plasma K+ - norm/high
92
Q

How to calculate osmolality

A

2(Na+) + urea + glucose

93
Q

Mx HHS

A

Aggressive fl
Low dose fixed IV insulin
Considder K+ replacement
Prophylactic LMWH

94
Q

How long in HHS can it take for electrolytes to return to normal?

A

72hrs

95
Q

Def hypogylcaemia

A

plasma glucose <3mmol/L

96
Q

Autonomic Sx - hypoglycaemia (5)

A
Sweating 
Anxiety 
Hunger 
Tremor 
Palpitations
97
Q

Neuroglycopenic Sx - hypoglycaemia (3)

A

Confusion
Drowsiness/coma
Seizure

98
Q

Effect of glucagon (3)

A

Increase glycogenolysis
Increase gluconeogenesis
Inhibit glycogen synthesis

99
Q

Adult causes hypoglycaemia with raised insulin (4)

A

Insulin admin
hypoglycaemia Dx (sulphonylureas)
Insulinomas
Septicaemia

100
Q

Adult causes of hypoglycaemia without raised insulin (3)

A

Sever liver/kidney disease
Hormonal + GF tumours
Hypopituitary, hypoadrenalism, low GH

101
Q

Mx hypoglycaemia - if can swallow

A

10-20g fasting acting carb
Recheck glucose 10-15 mins
When Sx improve - eat long acting carb

102
Q

Mx hypoglycaemia - if pt unconscious

A

1mg IM glucagon immediately
If doesn’t respond in 10 mins - call 999
In hospital - IV 100ml 20% glucose up to 3 times

103
Q

When is glucagon therapy for hypoglycaemia not effective?

A

If alcohol has been consumed

104
Q

Which microvascular structures are particularlya affected in diabetes?

A

Small vessels of retina, glomeruli and nn sheaths

105
Q

3 ways in which diabetes can affect the eyes

A

Diabetic retinopathy
Cataract
External ocular palsies

106
Q

Symmetrical polyneuropathy - pattern of sensory loss

A

Glove and stocking

107
Q

Which aspects of sensory loss are lost first in symmetrical polyneuropathy

A

Vibration
Deep pain
Temperature

108
Q

Other PS symmetrical polyneuropathy (4)

A

Pt losing balace when eyes closed
Walking on cotton wall
Interosseus wasting of small mm feet
Unrecognised trauma w/ poor healing –> ulcers

109
Q

What neuropathic arthropathy may develop from Symmetrical polyneuropathy

A

Charcot’s foot

110
Q

What is acute painful neuropathy?

A

Painful burning pains in feet, shins and ant thighs

111
Q

What is acute painful neuropathy associated with?

A

Poor glycaemic control

112
Q

At what time of day is acute painful neuropathy worst for patients?

A

Night

113
Q

When does acute painful polyneuropathy remit?

A

After 3-12 m of glycaemic control

114
Q

What are CN neuropathies occur in pt w/ DM?

A

III
IV
VI

115
Q

Which isolated peripheral nn lesions are more common in DM?

A

Nn compression syndromes e.g. carpal tunnel

Foot drop b/c lesions on sciatic nn

116
Q

What is mononeuritis multiplex?

A

When > 1 nn is affected by mononeuropathy

117
Q

What is diabetic amyotrophy?

A

Progressive wasting of mm tissues in DM

118
Q

PS diabetic amyotrophy

A

Painful wasting, typically of quadriceps mm
Norm middle aged men
Rare

119
Q

Sympathetic dysfunction - autonomic neuropathy (4)

A
--> 
postural HoTN
Ejaculatory failure 
Reduced sweating 
Horners syndrome
120
Q

Parasympathetic dysfunction - autonomic neuropathy (4)

A

Erectile dysfunction
Constipation
Urinary retention
Holmes Adie pupil

121
Q

When do renal complications manifest - T1DM

A

15-25y after diagnosis

122
Q

What is the leading cause of premature death in young diabetics?

A

CKD

123
Q

What % diabetics get nephropathy

A

30%

124
Q

Nephropathy testing

A

ev 6 months - microabuliminuria

125
Q

What should every pt w/ microalbuminuria be started on

A

ACEi

126
Q

Non-diabetic causes of microalbumin

A
Exercise 
UTI/inflamm 
Contamination of genital tract 
Acute illness - esp fever 
Cardiac failure 
HTN
127
Q

Macrovascular complications DM

A

Incr risk:
Stroke
MI
gangrene